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Abstract
Background: Alzheimer’s disease (AD) is a neurodegenerative disease of the brain and the most common form of
dementia in the elderly. Aneuploidy, a state in which cells have an abnormal number of chromosomes, has been
proposed to play a role in neurodegeneration in AD patients. Several studies using fluorescence in situ hybridization
have shown that the brains of AD patients contain an increased number of aneuploid cells. However, because the
reported rate of aneuploidy in neurons ranges widely, a more sensitive method is needed to establish a possible role
of aneuploidy in AD pathology.
Results: In the current study, we used a novel single-cell whole genome sequencing (scWGS) approach to assess
aneuploidy in isolated neurons from the frontal cortex of normal control individuals (n = 6) and patients with AD
(n = 10). The sensitivity and specificity of our method was shown by the presence of three copies of chromosome 21
in all analyzed neuronal nuclei of a Down’s syndrome sample (n = 36). Very low levels of aneuploidy were found in the
brains from control individuals (n = 589) and AD patients (n = 893). In contrast to other studies, we observe no selective
gain of chromosomes 17 or 21 in neurons of AD patients.
Conclusion: scWGS showed no evidence for common aneuploidy in normal and AD neurons. Therefore, our results
do not support an important role for aneuploidy in neuronal cells in the pathogenesis of AD. This will need to be
confirmed by future studies in larger cohorts.
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Background
Aberrant chromosome copy numbers, aneuploidy, has
been observed in the developing and adult human brain.
However, the reported frequency of neuronal aneuploidy
varies widely (up to 40 %, with an average of ~10 %)
[1–3] with some studies reporting no aneuploid cells at
all [4, 5]. Since neurons are post-mitotic, the number of
methods to screen for aneuploidy is limited and most
of the previous studies used interphase fluorescence in
situ hybridization (FISH). Interestingly, several recent
studies using single-cell whole genome sequencing
(scWGS) consistently found low levels (2–5 %) of aneu-
ploid neurons in the human brain [6–8]. Compared to
interphase FISH, which is intrinsically noisy [9], scWGS
has three important advantages: (1) all chromosomes in
each single cell can be analyzed (in contrast to a max-
imum of four chromosome-specific probes for inter-
phase FISH); (2) each chromosome is probed thousands
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of times per cell (thousands of unique reads per
chromosome representing distinct chromosomal re-
gions); and (3) the results are not affected by variable
probe hybridization or artifacts related to tissue sec-
tioning or other causes which can result in false-
positive or false-negative results. These advantages
make single-cell sequencing, at least in theory, a more
robust method for detecting aneuploidy.
Interestingly, aneuploidy is thought to be involved in
the pathogenesis of Alzheimer’s disease (AD), the most
common form of dementia [10]. Several studies have
reported an increased level of aneuploid cells in the
brains of AD patients [1, 5, 11–15]. For example, some
studies showed that extra copies of chromosomes 11,
17, 18, and 21 were more prevalent in neurons from
AD patients compared to controls [5, 11–13, 15]. In
contrast, other studies reported evidence for selective
aneuploidy such as a tenfold increase in chromosome
21 aneuploidy [12] or a twofold increase in X chromo-
some aneuploidy [14]. That extra copies of chromo-
some 21 were repeatedly described in AD neurons is
interesting in view of observations that individuals with
Down’s syndrome (DS), who also have an extra copy of
chromosome 21, are much more likely to develop AD
and at an earlier age than euploid individuals [16].
Based on such observations, it was postulated that tri-
somy of chromosome 21 and the resulting extra copy
of the amyloid precursor protein (APP) gene, located
on chromosome 21, could contribute to the pathogen-
esis of AD. Indeed, mutations in APP are observed in
patients with familial AD and are known to cause early
onset AD [17]. In contrast, Thomas and Fenech,
although finding high levels of aneuploidy in hippo-
campal cells for chromosome 17 and 21 (18 % and
12 % for chromosomes 17 and 21, respectively), found
no difference in aneuploidy rates from brains of AD
and controls [15], questioning the involvement of
trisomy 21 and 17 in the pathogenesis of AD.
Since the reported rates of aneuploidy in AD brains
are mostly based on interphase FISH studies and vary
widely, we used scWGS to re-examine neuronal
karyotypes in individuals with different stages of
dementia to determine the frequency of aneuploidy
in normal and AD brain. We developed a pre-
amplification-free library preparation method and
validated its ability to karyotype single cells by con-
firming the presence of three copies of chromosome
21 in single DS cells. We found very low levels of
aneuploid neurons in control and AD brains. Also,
no aneuploidy was found in non-neuronal cells of a
control and AD sample. Collectively, these results
show that aneuploidy is not common in normal and
AD brain and thus unlikely to contribute to the
pathogenesis of AD.
Results and discussion
Validation of the pre-amplification-free method of
preparing libraries
In this study, we used single-cell sequencing to assess
the presence of aneuploid cells in the frontal cortex of
normal postmortem brains and brains affected by AD
(Braak stage III to VI). The presence of amyloid plaques
in some of the brain samples classified with Braak stages
III and VI was confirmed by amyloid β (Aβ) staining
(Fig. 1). Nuclei were isolated from sections that were dir-
ectly adjacent to sections with amyloid plaques. Single
neuronal nuclei were sorted based on the nuclear neur-
onal marker NeuN as described previously [18]. scWGS
libraries were prepared without whole genome pre-
amplification (Additional file 1: Figure S1), reducing
PCR amplification bias and thereby maintaining a more
Fig. 1 Examples of beta-amyloid plaque staining. Representative
images of the area of the frontal cortex from where nuclei for
sequencing were isolated of control individual (a) or AD patients
with Braak stage III (b) or VI (c)
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direct correlation between sequence reads and genome
content. The distribution of reads across the chromo-
somes was used as a faithful indicator of the chromo-
some copy number. Since there is no pre-amplification
step, a particular genomic location is expected to be rep-
resented in libraries only twice, one from each homolog
of diploid individuals. Although the genomic coverage
without pre-amplification is low, losses of genomic DNA
during library preparation were typically found to be
random. As a result, the distribution of reads mapping
uniquely to the reference genome is rather even which
allows accurate calls of chromosome copy number.
The copy number state of each chromosome was de-
termined using an in-house developed algorithm called
Aneufinder [19]. Briefly, this algorithm bins the mapped
reads and uses a Hidden Markov Model (HMM) to pre-
dict the copy number state (i.e. monosomic, disomic,
trisomic, etc.) for each bin. The most common state of a
chromosome was assigned as the copy number for that
chromosome. This means that when the majority of a
chromosome is lost or gained, it is called monosomic or
trisomic, respectively. Only libraries that passed the
stringent quality metrics as determined by Aneufinder
were used for further analysis: out of a total of 2664
single-cell libraries prepared for this study, 1632 librar-
ies passed quality control (61 %). From these, we ob-
tained on average 858,800 reads per library, of which
333,000 reads (with MAPQ >10) mapped to a unique
location on the genome and library complexity was es-
timated to be 950,000 (see Additional file 2: Table S1
for more details). Importantly, the relatively shallow
sequencing of the single-cell libraries is sufficient to
determine chromosomal copy numbers. Higher cover-
age is possible by sequencing longer reads or fewer li-
braries per lane.
To ensure that our approach faithfully and reprodu-
cibly annotates aneuploid events, we first validated our
method by sequencing single neuronal nuclei isolated
from a fresh frozen postmortem brain sample from an
individual with DS. Indeed, in all 36 single-cell libraries,
we detected three copies of chromosome 21, but no fur-
ther aneuploidies (Fig. 2). In addition, two copies of
chromosome X were called, as expected from this female
individual. In contrast, all single neurons analyzed in our
study isolated from male individuals had only one copy
of the X-chromosome (Fig. 3a), further validating our
single-cell-sequencing platform. Finally, scWGS data of
several leukemic and solid tumor samples generated
using this platform, revealed similar overall copy num-
ber variation (CNV) patterns as obtained by array com-
parative genomic hybridization (CGH) analysis ([19];
Paranita et al., personal communication), validating
once more our approach to enumerate aneuploidy in
single cells.
Low level of aneuploidy in normal neurons
To assess the rate of aneuploidy in normal healthy
brains we examined neurons from six control individuals
without dementia. Of the 589 control neurons analyzed,
all but four were euploid (Fig. 3a and Additional file 3:
Figure S2A; Additional file 4: Table S2 and Additional
file 5: Table S3). These four aneuploid cells were found
in one control sample (n = 72): the first of which gained
a copy of chromosome 18, the second cell lost a copy of
chromosome 6, the third gained a copy of both chromo-
somes 4 and 16, and the fourth gained a copy of 13, 16,
21, and 22. Overall, the total prevalence of aneuploidy,
cells with loss or gain of one or more chromosomes, in
the control samples was 0.7 % (95 % confidence interval
[CI]: 0.2–1.8 %, n = 589). The aneuploidy per chromo-
some, cells with loss or gain of a specific chromosome,
was in the range of 0–0.34 % in Fig. 3a, Additional file 3:
Figure S2, Additional file 4: Table S2, and Additional
file 5: Table S3. The aneuploidy rates that we find in a
normal brain are remarkably lower than reported by most
other studies which used (interphase) FISH to detect an-
euploidy [1–5]. For example, when comparing these re-
sults with the per chromosome aneuploidy rates reported
by Iourov et al. [12] and Yurov et al. [14], we found sig-
nificantly lower aneuploidy rates for all of the chro-
mosomes analyzed in these studies (Mann–Whitney–
Wilcoxon rank test, p <0.05 for chromosomes 1, 7, 11,
14, 17, 18, 21, and X in Iourov et al. [12] and for
chromosomes 1, 7, 11, 16, 17, 18, and X in Yurov et al.
[14]) (Additional file 5: Table S3). The FISH-based
approach can yield noisy results, especially when used on
tissue slides (as opposed to single cell suspensions) [9].
Our results are more in agreement with other recent stud-
ies that sequenced single neurons [6–8] and reported low
rates (2–5 %) of aneuploid cells in normal brain. Similar
to our analysis, these studies all analyzed human frontal
cortical cells: McConnell et al. found one chromosome
loss and two gains in 110 neurons (2.7 %) [6], Cai et al.
reported four out of the 91 analyzed neurons to be
aneuploid (4.4 %) [7], and Knouse et al. found two
aneuploidies 89 cells (2.2 %) [8]. In summary, while our
pre-amplification-free single-cell sequencing method
faithfully detects aneuploidies such as trisomy 21 in a DS
individual (Fig. 2) or X-chromosome monosomy in male
cells (Fig. 3 and Additional file 3: Figure S2), it detects very
low levels of aneuploidy in human adult neurons, indicat-
ing that previous FISH approaches may have overesti-
mated aneuploidy levels in the human brain.
Low level of neuronal aneuploidy in AD
While several groups have reported an increased level of
aneuploidy in brains of AD patients compared to normal
healthy brains, these observations were also based on
FISH studies. Importantly, while our and other’s single-
van den Bos et al. Genome Biology  (2016) 17:116 Page 3 of 9
cell sequencing experiments [6–8] support that aneu-
ploidy in a healthy brain has been overestimated in FISH
studies, no single-cell sequencing data were available for
AD patients’ neurons. Therefore, we examined 893
neurons from ten individuals with AD to investigate a
potential role of neuronal aneuploidy in AD. In contrast
to previous studies, we did not find evidence for in-
creased aneuploidy in brains of AD patients (Fig. 3 and
Additional file 6: Figure S3, Table 1, Additional file 4:
Table S2, and Additional file 5: Table S3). In seven
patients, no aneuploid cells were found, while in the other
three patients, out of 261 cells a total of five aneuploid
cells were found. Of the neurons from AD2 one cell had
an extra copy of chromosome 6, of AD9 two cells lost
either chromosome 3 or 21, and in AD10 one cell lost
chromosome 12 and another gained chromosome 22. No
evidence for increased rates of trisomy 21 in the assessed
AD samples was found (Table 1 and Additional file 5:
Table S3). The total neuronal aneuploidy rates in AD were
comparably low as in control samples (0.6 %, 95 % CI:
0.2–1.3 %, n = 893). Again, these aneuploidy rates are
significantly lower than reported previously (Mann–
Whitney–Wilcoxon rank test, p <0.001 for chromosomes
1, 7, 11, 14, 17, 18, 21, and X in Iourov et al. [12] and for
chr1, 7, 11, 16, 17, 18, and X in Yurov et al. [14]). Im-
portantly, we can exclude detection issues, as we observed
trisomy 21 in all neurons sampled from a DS control indi-
vidual. Furthermore, we failed to detect selective gains of
the other recurring AD chromosome gains reported in
AD (e.g. trisomy 11 and 17). In fact, the few aneuploidies
we did detect appeared to be random, as no particular
chromosome loss or gain was found in more than two cells.
Interestingly, a recent study using single-cell quantita-
tive PCR reported the presence of local copy number
gains, up to 12 copies, of the APP locus in AD neurons
[20]. Even though the goal of our scWGS study was to
examine whole chromosome copy number variation, we
investigated this region more closely in AD neurons. No
copy number gains of the APP locus were observed
(Additional file 7: Figure S4).
Although we do not observe a selective gain of
chromosome 21 in neurons from AD patients, there is
still a very compelling observation that individuals with
DS develop early onset dementia with brain lesions simi-
lar as observed in AD patients [16]. As we focused our
sequencing efforts on neurons only, we cannot rule out
the possibility that aneuploidy in other cell lineages in
the brain is involved in the pathogenesis of AD. Increasing
evidence suggests an important contribution of the im-
mune system to AD pathogenesis (reviewed in [21, 22]).
Both microglia and astrocytes, the CNS-resident innate
immune cells, have been shown to be involved in the on-
set and progression of AD. So far, no single-cell sequen-
cing data are available of these types of cells from AD
brains. Therefore, we also analyzed some non-neuronal
(NeuN-negative) nuclei from a control (n = 63) and an AD
Fig. 2 Trisomy of chromosome 21 is detected in DS cells. a Genome wide copy number plot of a single DS cell. Arrow denotes gain as identified
by AneuFinder. b Genome wide copy number profile of a population of DS cells (n = 36). Each row represents a single cell with chromosomes
plotted as columns. Cells are clustered based on the similarity of their copy number profile. Copy number states are depicted in different colors
(see legend)
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(n = 51) sample by scWGS. We found no aneuploid cells
in either of these non-neuronal controls (Fig. 4 and
Additional file 5: Table S3). However, no clear distinction
was made between the non-neuronal cells and further
studies are needed to exclude a potential role of aneu-
ploidy in cell types such as microglia or astrocytes in AD
neurodegeneration.
Taken together, our analysis using scWGS reveals that
the prevalence of aneuploid cells in the frontal cortex of
control individuals and AD patients is very low.
Conclusions
Many recent studies have reported a high prevalence of
aneuploid neurons in AD brains, which led to the
hypothesis that neuronal aneuploidy could be involved
in the pathogenesis of AD. However, using a single-cell
sequencing approach, we report low levels of aneuploidy
both in neurons from AD patients as well as in neurons
from non-diseased individuals. The level of neuronal
aneuploidy in our study is much lower than was previ-
ously reported [1, 5, 11–15]. Nevertheless several lines
Fig. 3 scWGS reveals no common aneuploidy in AD neurons. A representative genome wide copy number profile of a population of cells from
control 6 (male, n = 120) (a) and two AD patients AD 2 (male, n = 37) and AD 4 (female, n = 72) (b) sample. Each row represents a single cell with
chromosomes plotted as columns. Cells are clustered based on the similarity of their copy number profile. Copy number states are depicted in
different colors (see legend)
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of evidence strongly support our results. First, our
method clearly detected trisomy of chromosome 21 in a
DS sample and monosomy of chromosome X in all male
samples showing the accuracy of our approach. Import-
antly, the validity of our scWGS method to study CNVs
in leukemic and solid tumor samples was validated with
array CGH in separate studies ([19], Paranita et al.,
personal communication). The study by Bakker et al.
[19] also provides evidence that our technique can
detect complex and partial aneuploidies. Second, the an-
euploidy rates that we find in normal healthy neurons
are more in line with recent findings from other single-
cell sequencing studies [6–8]. Third, we analyzed over
1500 neuronal nuclei, which is to our knowledge the
largest single cell sequencing dataset so far. Therefore,
although more AD-affected brains should be assessed to
exclude rare cases, our results do not support an im-




Fresh-frozen postmortem brain samples from the frontal
cortex were obtained from the Dutch Brain Bank and
from the department of Pathology & Medical Biology of
the University Medical Center Groningen (UMCG). In
this study, samples from six non-demented controls
(Braak stage 0–I) and ten AD patients (Braak stage III–VI)
were used. Patient details are listed in Table 1. A fresh-
frozen postmortem brain sample from an individual with
DS served as a positive control for the detection of trisomy
of chromosome 21.
Amyloid plaque staining
Amyloid staining was performed to confirm the presence
of amyloid plaques in the brain samples with Braak stage
III and VI. Immunohistochemical staining with anti-
bodies directed at Aβ (4G8, 1:500, Biolegend, 800702)
was done on 10-μm frozen brain sections. The sections
were pre-incubated in 0.3 % H2O2 for 30 min and
blocked with 10 % normal horse serum in PBS with
0.3 % Triton-X100 (Sigma, 9002-93-1) for 30 min. Here-
after, sections were incubated overnight at 4 °C with the
Aβ primary antibody in PBS containing 0.3 % Triton-
X100 and 1 % normal goat serum. Unbound antibodies
were washed away with PBS and sections were incubated
for 1 h at room temperature with horse anti-mouse bio-
tinylated secondary antibody (1:400, Vector, BA-2000).
Finally, the sections were incubated in avidin-biotin-
peroxidase complex (Vectastain ABC kit, Vector
Laboratories, PK-6100) for 30 min and visualized with
diaminobenzidine (Sigma, D-5637). Counterstaining was
performed with cresyl violet for 2 min.
Isolation of neuronal and non-neuronal nuclei
From each sample, ten sections of 50 μm or a small
tissue block (~0.5–1 cm2), cut into pieces, was used for
nuclei isolation. Neuronal nuclei isolation was per-
formed as described previously [18] with minor modifi-
cations. Samples were kept on ice throughout the nuclei
Table 1 Brain samples used and aneuploidy levels found per sample
Sample ID Age Sex Braak stage Libraries passing QC Aneuploid cells
Control 1 69 M 0 81 0 (0 %)
Control 2 74 M 0 80 0 (0 %)
Control 3 79 F I 108 0 (0 %)
Control 4 82 F 0 72 4 (5.56 %)
Control 5 84 F I 128 0 (0 %)
Control 6 93 M I 120 0 (0 %)
AD 1 64 F VI 32 0 (0 %)
AD 2 66 M IV 37 1 (2.70 %)
AD 3 73 F V 63 0 (0 %)
AD 4 74 F V 72 0 (0 %)
AD 5 76 F III 118 0 (0 %)
AD 6 80 F VI 125 0 (0 %)
AD 7 85 F III 115 0 (0 %)
AD 8 85 F VI 107 0 (0 %)
AD 9 91 F III 109 2 (1.83 %)
AD 10 92 F VI 116 2 (1.72 %)
Non-neuron control 84 F I 63 0 (0 %)
Non-neuron AD 92 F VI 51 0 (0 %)
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isolation procedure. In short, tissue sections were incu-
bated in nuclear isolation buffer (10 mM Tris-HCl
[pH 8], 320 mM sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2,
0.1 mM EDTA, 1 mM dithiothreitol [DTT], and 0.1 %
Triton X-100) for 5 min and filtered through a 70-μm
filter using a plunger. Hereafter, nuclei were purified by
ultracentrifugation (107,000 g for 2.5 h at 4 °C) through
a dense sucrose buffer (10 mM Tris-HCl (pH 8), 1.8 M
sucrose, 3 mM Mg(Ac)2, 0.1 mM EDTA, and 1 mM
DTT). Supernatant was removed from the pelleted
nuclei that were washed and resuspended in PBS con-
taining 2 % bovine serum albumin (BSA) (PBS/2%BSA).
Isolated nuclei were stored in nuclei storage buffer
(50 mM Tris-HCl [pH 8], 5 mM Mg(Ac)2, 0.1 mM
EDTA, 5 mM DTT, and 40 % glycerol) at –80 °C. On
the day of sorting, nuclei were washed with PBS/2%BSA
and resuspended in PBS/2%BSA containing an antibody
directed against the nuclear neuronal marker NeuN
(1:100.000, Millipore) and 4′,6-diamidino-2-phenylindole
(DAPI; 10 μg/mL) and incubated for 45–60 min on ice.
Single NeuN-positive or NeuN-negative and DAPI low
nuclei were sorted into 5 μL freezing buffer (50 % PBS,
7.5 % DMSO, and 42.5 % 2X ProFreeze-CDM [Lonza])
in individual wells of a 96-well plate using MoFlo-Astrios
(Beckman Coulter). Ninety-two single nuclei were sorted
per plate. In two wells of each plate, ten nuclei were sorted
as positive control and two wells without nuclei served as
negative control. Plates were subsequently centrifuged at
500 g for 5 min at 4 °C before being gradually frozen to –
80 °C in styrofoam boxes. Plates were stored at –80 °C
until library preparation.
Pre-amplification-free scWGS library preparation
Pre-amplification-free scWGS library preparation was
performed using a modified version of a protocol de-
scribed before [23]. All pipetting steps are performed
using a Bravo Automated Liquid Handling Platform
(Agilent Technologies, Santa Clara, CA, USA). All DNA
purification steps between enzymatic reactions were
performed using AMPure XP magnetic beads (Agencourt
AMPure, Beckman Coulter, Brea, CA, USA). All enzymes
used in the library preparation are obtained from New
England Biolabs. After DNA fragmentation by micrococ-
cal nuclease, end repair, and A-tailing of the DNA
fragments was performed in one reaction mix including
T4 DNA polymerase, T4 polynucleotide kinase, and Bst
2.0 warm start polymerase. End repair was performed at
25 °C for 30 min followed by the A-tailing reaction at
68 °C for 30 min. Subsequently without DNA puri-
fication, ligation reaction mixture containing T4 DNA
ligase was added and Illumina PE forked adapters were
ligated to either side of the DNA fragments. After clean
up, the adapter containing DNA fragments were
directly subjected to 17 cycles of PCR using Phusion
High Fidelity DNA polymerase and custom barcoded
primers. After PCR amplification, a final AMPure bead
clean-up was performed and DNA was eluted in 6 μL
elution buffer.
Fig. 4 scWGS reveals no common aneuploidy in AD non-neuronal cells. Whole genome copy number profiles from non-neuronal cells from
control 5 (female, n = 63) (a) and AD 10 (female, n = 51) (b). Each row represents a single cell with chromosomes plotted as columns. Cells are
clustered based on the similarity of their copy number profile. Copy number states are depicted in different colors (see legend)
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Illumina sequencing
Since each single-cell library received a unique barcode,
libraries can be pooled (multiplexed) and sequenced to-
gether. Per 96-well plate, the full volume (6 μL) of the
single nuclei and negative controls were pooled together
with 1 μL of the ten nuclei controls. Size selection was
performed on a 2 % E-gel EX (Invitrogen) to isolate the
mononucleosome fragments of approximately 280 bp
(range of 200–400 bp). The DNA was eluted from the
gel slices using Zymoclean gel DNA recovery kit (Zymo)
according to the manufacturer’s protocol. The DNA
quantity and quality were assessed using Qubit fluo-
rometer (Invitrogen) and Bioanalyzer with High sensitiv-
ity chips (Agilent), respectively. For sequencing, clusters
were generated on the cBot and single-end 50 nt reads
were generated using the HiSeq2500 sequencing plat-
form (Illumina, San Diego, CA, USA). In all runs, a pool
of 192 libraries was sequenced on one lane of a flow cell.
Data analysis
After demultiplexing, all reads were aligned to the hu-
man reference genome (GRCh37) using short read
aligner Bowtie2 (version 2.2.4) [24] with default settings.
The resulting BAM files were sorted using Samtools
(version 0.1.18) [25] and duplicate reads were marked
using BamUtil (version 1.0.3). Duplicate reads and am-
biguous alignments (MAPQ >10) were filtered out using
Aneufinder. Estimated complexity was calculated by
downsampling the reads several times and determining
the fraction of unique reads each time. Then the number
of reads sequenced (seq_reads) was plotted against the
number of unique reads (uni_reads) and a curve was
fitted through the data points using the formula:
uni reads ¼ Cmax  seq readsð Þ= K þ seq readsð Þ;
where Cmax was used as an estimation of the complexity
of the library: the theoretical maximum unique reads in
that library. K is the number of sequenced reads at
which the number of unique reads is half of the library
complexity. For subsequent CNV assessment, a custom
pipeline was developed called AneuFinder [19]. Briefly,
uniquely mapped reads are counted in, non-overlapping
bins of variable size based on mappability with a mean
of 1 Mb in size (for details: see Bakker et al. [19]). GC
corrected uniquely mapped read counts, were used as
observables in a Hidden Markov Model (HMM) with
several possible hidden copy number states from nullis-
omy up to decasomy (ten copies). The emission distribu-
tions were modeled with a delta distribution for the
nullsomy state and with negative binomial distributions
for all other states, with means and variances that were
fixed to multiples of the monosomy-state ones. Param-
eter estimates were obtained using the Baum–Welch
algorithm. The final CNV calls were determined as the
state with the highest posterior probability for each bin.
Quality control
The quality of each library was assessed with several
criteria: genomic coverage, bin-to-bin variation in read
density (spikiness), entropy, number of ploidy state seg-
ments, and Bhattacharyya distance. Using the AneuFinder
function “ClusterByQuality,” the libraries were clustered
based on similarity of the quality control aspects
(described in detail in Bakker et al. [19]). From each
sample, the highest quality cluster, each of which had spiki-
ness <0.21 and Bhattacharyya distance >1.0, were consid-
ered good quality libraries and used for aneuploidy calling.
Statistics
Wilcoxon rank sum test was used to compare groups
using wilcox.test in R. P values <0.05 were considered
significant.
Additional files
Additional file 1: Figure S1. Single-cell, pre-amplification-free library
preparation protocol overview. Schematic representation of the library
preparation protocol used: after sorting in 96-well plates, the DNA is
fragmented using MNase. End repair and A-tailing are combined in one
reaction and directly followed with ligation of the adapters. Barcodes are
introduced during the PCR and after pooling and size selection the
libraries are ready to be sequenced. (PDF 203 kb)
Additional file 2: Table S1. Statistics of all single-cell libraries passing
quality control. (XLSX 220 kb)
Additional file 3: Figure S2. scWGS reveals no common aneuploidy in
controls. Genome wide copy number profiles from single-cell libraries of five
control individuals. Each row represents a single cell with chromosomes
plotted as columns. Cells are clustered based on the similarity of their
copy number profile. Copy number states are depicted in different colors
(see legend). (PPTX 327 kb)
Additional file 4: Table S2. Copy number states from all chromosomes
of all libraries. (XLSX 141 kb)
Additional file 5: Table S3. Aneuploidy rates per chromosome of all
samples. (XLSX 13 kb)
Additional file 6: Figure S3. scWGS reveals no common aneuploidy in
AD. Genome wide copy number profiles from single-cell libraries of eight
AD patients. Each row represents a single cell with chromosomes plotted
as columns. Cells are clustered based on the similarity of their copy
number profile. Copy number states are depicted in different colors
(see legend). (PDF 1238 kb)
Additional file 7: Figure S4. No local copy number variations at APP
locus in AD neurons. UCSC genome browser view of the APP locus on
chromosome 21 for all AD libraries (n = 893; left) and zoomed in for some
libraries (right). (PDF 600 kb)
Abbreviations
AD: Alzheimer’s disease; APP: amyloid precursor protein; Aβ: amyloid β;
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